APA (7th ed.) Citation

Puledda, F., Younis, S., Huessler, E., Haghdoost, F., Lisicki, M., Goadsby, P. J., & Tassorelli, C. (2023). Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature. Cephalalgia, 43(3), 1. https://doi.org/10.1177/03331024231151419

Chicago Style (17th ed.) Citation

Puledda, Francesca, Samaira Younis, Eva-Maria Huessler, Faraidoon Haghdoost, Marco Lisicki, Peter J. Goadsby, and Cristina Tassorelli. "Efficacy, Safety and Indirect Comparisons of Lasmiditan, Rimegepant, and Ubrogepant for the Acute Treatment of Migraine: A Systematic Review and Network Meta-analysis of the Literature." Cephalalgia 43, no. 3 (2023): 1. https://doi.org/10.1177/03331024231151419.

MLA (9th ed.) Citation

Puledda, Francesca, et al. "Efficacy, Safety and Indirect Comparisons of Lasmiditan, Rimegepant, and Ubrogepant for the Acute Treatment of Migraine: A Systematic Review and Network Meta-analysis of the Literature." Cephalalgia, vol. 43, no. 3, 2023, p. 1, https://doi.org/10.1177/03331024231151419.